Drawing for BIOPHARM INSIGHT

USPTO serial 86315630

BIOPHARM INSIGHT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
KIM, SOPHIA SUJIN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIOPHARM INSIGHT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Thomas J. Donovan

Thomas J. Donovan Barnes & Thornburg LLPP.O. Box 2786Chicago, IL 60690-2786UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Electronic publications, namely, reports, books and newsletters in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning recorded on computer media; digital media and recordings, namely, pre-recorded DVDs, downloadable audio and video recordings, and CDs in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; electronic books in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning recorded on computer media; downloadable electronic publications in the nature of reports, books and newsletters in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; downloadable digital media and recordings namely, electronic video recordings in the fields of biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; Downloadable electronic data files featuring data in the fields of mergers, acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; computer software for desktop publishingACTIVE—
035Advertising services; business management; business administration services and managing office functions in the nature database management for others; business information management services; business consultancy services; business management and organisation consultancy services; provision of business and commercial information for the academic and scientific, and professional and business communities in the fields of biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; business research services; commercial information agency services; provision of statistical information for business and commercial purposes in the field of business investments, mergers and acquisitions; conducting public opinion polling services; conducting market opinion polling studies; compilation and systemisation of information into computer databases; computerised file managing; document reproduction; arranging newspapers and magazine subscriptions for others; news clipping services; publication of publicity texts; marketing research and marketing research studies; arranging and conducting exhibitions, conferences, congresses, conventions and trade shows for business and commercial purposes; data retrieval services, namely, providing an on-line searchable database featuring business information and commercial information; business information and advisory services; research and analysis in the fields of economics; providing business information and business news relating to business mergers, business acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs industry, biotechnology medical products industry, biotherapeutics industry, and biologicals and related research and development industries; preparing financial reports for others; preparing financial reports for others via the Internet, telecommunication and other electronic communication networks; providing information and news in the fields of mergers and acquisitions of corporationsACTIVE—
036Financial advice and consultancy services; financial research, analysis, forecasting and advisory services; financial information; financial information relating to mergers, acquisitions, corporate transactions, debt finance, debt trading and debt issuance; debt collection services; financial information evaluation, appraisal, forecasting and reporting; financial analysis; financial research services; financial information and financial advisory services; financial advice and consultancy services provided online via the Internet, telecommunication and other electronic communication networks; financial research, analysis, forecasting and advisory services provided online via the Internet, telecommunication and other electronic communication networks; financial information provided online via the Internet, telecommunication and other electronic communication networks; financial information relating to mergers, acquisitions, corporate transactions, debt finance, debt trading and debt issuance provided online via the Internet, telecommunication and other electronic communication networks; debt collection services provided online via the Internet, telecommunication and other electronic communication networks; financial information evaluation, appraisal, forecasting and reporting provided online via the Internet, telecommunication and other electronic communication networks; financial analysis provided online via the Internet, telecommunication and other electronic communication networks; financial research services provided online via the Internet, telecommunication and other electronic communication networks; financial information and financial advisory services provided online via the Internet, telecommunication and other electronic communication networks; providing information and news in the fields of corporate financial transactions, debt finance, debt trading, debt issuance, investment advice on biotechnology drugs, investment advice on biotechnology medical products, investment advice on biotherapeutics and investment advice on biologicals and related research and development companies, investment strategies for high net worth individuals, and financial retirement planning; providing financial information and financial news relating to business mergers, business acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs industry, biotechnology medical products industry, biotherapeutics industry, and biologicals and related research and development industries, investment strategies for high net worth individuals, and retirement planningACTIVE—
041Education services, namely, providing of training in the fields of business mergers, business acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; arranging and conducting seminars in the fields of business mergers, business acquisitions, corporate transactions, debt finance, debt trading, debt issuance, biotechnology drugs, biotechnology medical products, biotherapeutics and biologicals and related research and development, investment strategies for high net worth individuals, and retirement planning; library services provided by means of a computer database which feature on-line newspapers, magazines, photographs and pictures via an on-line computer network; publication of reports, books and newsletters in the field of financial information, financial reports and financial analysisACTIVE—
042Providing scientific information and related research and development information in the fields of biotechnology drugs, biotechnology medical products, biotherapeutics, and biologicalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 16, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 15, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 4, 2017CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 4, 2017COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 4, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 4, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 17, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 15, 2017EX3GSOU EXTENSION 3 GRANTED—
Jun 15, 2017EXT3SOU EXTENSION 3 FILED—
Jun 15, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 17, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 15, 2016EX2GSOU EXTENSION 2 GRANTED—
Dec 15, 2016EXT2SOU EXTENSION 2 FILED—
Dec 15, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 22, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 21, 2016EX1GSOU EXTENSION 1 GRANTED—
Jul 20, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 14, 2016EXT1SOU EXTENSION 1 FILED—
Jun 14, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 15, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 20, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 20, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 30, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 14, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 8, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 11, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 10, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 10, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 22, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 22, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 22, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 8, 2015ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
May 5, 2015PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Apr 17, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 15, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 31, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 31, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 31, 2015ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Feb 3, 2015GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Feb 3, 2015GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 3, 2015CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 30, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 30, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 30, 2014ALIEASSIGNED TO LIE—
Dec 17, 2014ALIEASSIGNED TO LIE—
Dec 9, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 9, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 9, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 9, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 29, 2014DOCKASSIGNED TO EXAMINER—
Jun 28, 2014MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jun 27, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 24, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance